ResearcherWenzhou Medical UniversityActive in the last 2 years
Zhiqing Lin
Matched on ORCID iD 0009-0003-2112-8521; OpenAlex author ID A5071849395. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 4
- ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. First author DOI 10.1038/s42003-025-07897-0↗
- Retraction Note: Palmitoyl transferases act as novel drug targets for pancreatic cancer. Co-author DOI 10.1186/s12967-024-05202-x↗
- Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Co-author DOI 10.1016/j.biopha.2023.114567↗
- Palmitoyl transferases act as novel drug targets for pancreatic cancer. Co-author DOI 10.1186/s12967-023-04098-3↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xin Liu · 3 shared papers, 2023–2024 · strength 0.73
- Paper Retraction Note: Palmitoyl transferases act as novel drug targets for pancreatic cancer. DOI 10.1186/s12967-024-05202-x↗
- Paper Palmitoyl transferases act as novel drug targets for pancreatic cancer. DOI 10.1186/s12967-023-04098-3↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Keke Huang · 3 shared papers, 2023–2024 · strength 0.73
- Paper Retraction Note: Palmitoyl transferases act as novel drug targets for pancreatic cancer. DOI 10.1186/s12967-024-05202-x↗
- Paper Palmitoyl transferases act as novel drug targets for pancreatic cancer. DOI 10.1186/s12967-023-04098-3↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Hui Guo · 2 shared papers, 2023–2025 · strength 0.42
- Paper ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. DOI 10.1038/s42003-025-07897-0↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Wei Mei Guo · 2 shared papers, 2023–2025 · strength 0.42
- Paper ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. DOI 10.1038/s42003-025-07897-0↗
- Paper Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor m… DOI 10.1016/j.biopha.2023.114567↗
- Peng Zhang · 1 shared paper, 2023 · strength 0.15
- Jianmin Wu · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.